NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway

Abstract Glioblastoma (GBM) is one of the most lethal primary brain tumor with a poor median survival less than 15 months. Despite the development of the clinical strategies over the decades, the outcomes for GBM patients remain dismal due to the strong proliferation and invasion ability and the acq...

Full description

Bibliographic Details
Main Authors: Jianyang Xiang, Wahafu Alafate, Wei Wu, Yichang Wang, Xiaodong Li, Wanfu Xie, Xiaobin Bai, Ruichun Li, Maode Wang, Jia Wang
Format: Article
Language:English
Published: Nature Publishing Group 2022-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-04512-6

Internet

https://doi.org/10.1038/s41419-022-04512-6

Similar Items